Journal of cosmetic dermatology · 2026
Novel and Simple Punch Treatment for Xanthelasma Palpebrarum: A Preliminary Case Series.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cheng Hui, Yao Wende, Bai Yun, Li Xinyi, Li Xiaojing
Аннотация
BACKGROUND: Xanthelasma palpebrarum (XP) is a common cutaneous condition of the eyelid, which compromises eyelid aesthetics. Non-surgical treatments are often limited by multiple sessions and high cost. Surgical treatment, although effective, is constrained by the limited availability of eyelid skin and the risk of ectropion. A simple, safe, and effective therapeutic technique is essential for managing XP.
AIMS: This study aimed to present a new dermatologic treatment for XP and assess its effectiveness.
METHODS: A novel technique, punch-assisted xanthelasma nucleus excision (PAXNE), was applied in four cases of mild-to-moderate XP (Grades I and II) under local anesthesia. Clinical photographs of the patients at the preoperative and postoperative follow-up for 1 month were recorded. Treatment outcomes were assessed at a 1-month follow-up using a 5-Likert scale for periorbital aesthetics and patient satisfaction. Additionally, two independent physicians evaluated treatment efficacy based on lesion clearance (0-4 Scale).
RESULTS: Postoperative scarring was inconspicuous, and aesthetic outcomes were satisfactory at the 1-month follow-up. After 1-month follow-up, the average 5-Likert scale score for periorbital aesthetics was 3.25, and the average patient satisfaction score was 3.75. The objective treatment efficacy score reached 4.0 for all cases, indicating over 75% clearance of the lesions. No postoperative complications, such as eyelid ectropion, were found in the preliminary series.
CONCLUSIONS: PAXNE is a promising, minimally invasive approach showing excellent short-term aesthetic results, but it needs more investigation in larger cohorts with long-term follow-up.
AIMS: This study aimed to present a new dermatologic treatment for XP and assess its effectiveness.
METHODS: A novel technique, punch-assisted xanthelasma nucleus excision (PAXNE), was applied in four cases of mild-to-moderate XP (Grades I and II) under local anesthesia. Clinical photographs of the patients at the preoperative and postoperative follow-up for 1 month were recorded. Treatment outcomes were assessed at a 1-month follow-up using a 5-Likert scale for periorbital aesthetics and patient satisfaction. Additionally, two independent physicians evaluated treatment efficacy based on lesion clearance (0-4 Scale).
RESULTS: Postoperative scarring was inconspicuous, and aesthetic outcomes were satisfactory at the 1-month follow-up. After 1-month follow-up, the average 5-Likert scale score for periorbital aesthetics was 3.25, and the average patient satisfaction score was 3.75. The objective treatment efficacy score reached 4.0 for all cases, indicating over 75% clearance of the lesions. No postoperative complications, such as eyelid ectropion, were found in the preliminary series.
CONCLUSIONS: PAXNE is a promising, minimally invasive approach showing excellent short-term aesthetic results, but it needs more investigation in larger cohorts with long-term follow-up.